Skip to main content

Scope Biosciences

Wageningen, The Netherlands

Scope Biosciences is a on-site development platform technology specializing in the development of molecular diagnostics using CRISPR-Cas.

$1.2M raised
Jun 2025
Seed

Top Investors

SHIFT InvestOostNLEIC AcceleratorGenome Diagnostics

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Scope Biosciences

How much funding has Scope Biosciences raised?
Scope Biosciences has raised $1.2M in total funding. The most recent round was Seed. The last funding was announced in June 2025.
Who are Scope Biosciences's investors?
Scope Biosciences's investors include SHIFT Invest, OostNL, EIC Accelerator, Genome Diagnostics.
Where is Scope Biosciences headquartered?
Scope Biosciences is headquartered in Wageningen, The Netherlands.
What does Scope Biosciences do?
Scope Biosciences is a on-site development platform technology specializing in the development of molecular diagnostics using CRISPR-Cas.
What stage is Scope Biosciences at?
Scope Biosciences is at the Seed stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Scope Biosciences — Funding & Investors." VCBacked, June 16, 2025, https://www.vcbacked.co/company/scope-biosciences. Accessed June 4, 2026.
APA
VCBacked. (2025). Scope Biosciences — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/scope-biosciences
Wikipedia (cite web)
{{cite web |title=Scope Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/scope-biosciences |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .